Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.175 USD | +2.09% | +20.55% | +72.31% |
05-14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
05-14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.31% | 582M | |
+28.81% | 49.46B | |
+0.40% | 42.58B | |
+49.22% | 42.49B | |
-5.26% | 29.09B | |
+12.24% | 26.61B | |
-24.24% | 18.64B | |
+7.35% | 13.16B | |
+32.01% | 12.55B | |
+24.12% | 12.1B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Transcript : Taysha Gene Therapies, Inc. - Analyst/Investor Day